Indonesia Biomaterials in Healthcare Market Analysis Report [2022-30] I Insights10

Indonesia Biomaterials in Healthcare Market Analysis

$ 3999

The Indonesia Biomaterials in Healthcare Market is expected to witness growth from $938 Mn in 2022 to $2528 Mn in 2030 with a CAGR of 13.20% for the forecasted year 2022-2030. As Indonesia's economy expands, disposable incomes rise and people are starting to care more about their health. This will probably increase demand for healthcare services and items, as well as for the biomaterials used in medical equipment and other applications. The market is segmented by type and by application. Some key players in this market include: PT Dharma Medipro, PT Citra Medika Lestari, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.

ID: IN10IDMD003 CATEGORY: Medical Devices GEOGRAPHY: Indonesia AUTHOR: Jigyasu Bhandari

Buy Now

Indonesia Biomaterials in Healthcare Market Executive Analysis

the forecast period. Between 2022 and 2028, Indonesia is anticipated to increase its healthcare spending by $30.18 billion. In 2028, spending is anticipated to reach $69.3 billion. Indonesia is thought of as such because it has recently industrialised and has a middle income. In terms of nominal GDP, it is the 17th largest economy in the world and the 7th largest in terms of GDP. By 2025, Indonesia's estimated $40 billion Internet economy is projected to reach $130 billion.

Biomaterials can be used in wound healing applications to promote tissue regeneration and prevent infection. They can also be used to create dressings and bandages that speed healing and lessen scarring. Biomaterials are used in orthopaedics to make implants and prostheses for joint replacement surgeries, bone repair, and reconstruction. These materials can be designed to mimic the properties of natural bone and promote bone growth The Indonesia Biomaterials in Healthcare Market size is at around $938 Mn in 2022 and is projected to reach $2528 Mn in 2030, exhibiting a CAGR of 13.20% during, making them an excellent option for treating fractures and other bone-related injuries. Biomaterials can be used to create scaffolds that aid in the growth and regeneration of various types of tissue, including skin, cartilage, and bone. This technology allows for the repair of damaged body tissue as well as the growth of new tissue for transplantation.

inndonesia biomaterials in healthcare market

Market Dynamics

Market Growth Drivers

As Indonesia's economy expands, disposable incomes rise and people are starting to care more about their health. This will probably increase demand for healthcare services and items, as well as for the biomaterials used in medical equipment and other applications. The demand for medical implants, such as artificial joints, dental implants, and cardiovascular devices, is rising quickly due to an ageing population and an increase in the prevalence of chronic diseases. As a result of the extensive use of biomaterials in the creation of these implants, suppliers to the healthcare industry are probably going to see high demand. The growth of Indonesia's Biomaterials in Healthcare market, is actively encouraged by the government. This entails offering financial incentives, putting in place legal frameworks, and funding R&D. These actions will probably foster a supportive atmosphere for producers of biomaterials, fostering the market's expansion.

Market Restraints

The cost of producing biomaterials in Indonesia can be high, and manufacturers may be forced to compete with less expensive alternatives like long-used, conventional materials or equipment. It might be difficult to gain momentum in the Indonesian Biomaterials in Healthcare market as a result, and to make enough money to support ongoing R&D projects.

Competitive Landscape

Key Players

PT Dharma Medipro (ID)
PT Citra Medika Lestari (ID)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Notable Recent Deals

2021: PT Kingfa Sci & Tech Indonesia, a manufacturer of biomaterials, has purchased a majority stake from PT Gajah Tunggal Tbk, a well-known tyre manufacturer. Through this purchase, PT Gajah Tunggal Tbk was able to extend its product line to include biomaterials and enter the healthcare sector.

Healthcare Policies and Regulatory Landscape

The National Agency of Drug and Food Control (BPOM) and the Ministry of Health oversee the regulatory framework and healthcare policies in Indonesia's Biomaterials in Healthcare industry. Before being marketed and distributed in Indonesia, medical devices, including biomaterials, must be registered with the BPOM. Examining safety and effectiveness statistics as well as manufacturing and quality control procedures are all part of the registration process. Good Manufacturing Practice (GMP) guidelines must be followed by biomaterial producers in order to guarantee the standard and security of their goods. To make sure GMP rules are being followed, the BPOM regularly inspects manufacturing facilities. A pharmacovigilance system has been created by the Ministry of Health to keep an eye on the efficacy and safety of biomaterials sold on the Indonesian market. Manufacturers are obliged to notify the BPOM of any unfavourable incidents related to their products.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Indonesia market in 2019. The growing geriatric population Indonesialy is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.